GB840358A - Improvements in or relating to the manufacture of n-mono-substituted piperazines - Google Patents

Improvements in or relating to the manufacture of n-mono-substituted piperazines

Info

Publication number
GB840358A
GB840358A GB3189057A GB3189057A GB840358A GB 840358 A GB840358 A GB 840358A GB 3189057 A GB3189057 A GB 3189057A GB 3189057 A GB3189057 A GB 3189057A GB 840358 A GB840358 A GB 840358A
Authority
GB
United Kingdom
Prior art keywords
monopiperazinium
methyl
alkylating
aralkylating
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3189057A
Inventor
Bernard George Boggiano
Geoffrey Baldwin Jackman
Vladimir Petrow
Oliver Stephenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BDH Chemicals Ltd
Original Assignee
BDH Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BDH Chemicals Ltd filed Critical BDH Chemicals Ltd
Priority to GB3189057A priority Critical patent/GB840358A/en
Publication of GB840358A publication Critical patent/GB840358A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/023Preparation; Separation; Stabilisation; Use of additives

Abstract

N-mono-substituted piperazines are prepared by reacting, in the presence of an organic or aqueous organic solvent, an alkylating agent containing up to 6 carbon atoms or an aralkylating agent with a monopiperazinium salt derived from an acid with dissociation constant lying below the second acid dissociation constant of the piperazine in the solvent system used for the condensation. Suitable monopiperazinium salts are, for example, those derived from acetic, succinic, citric, benzoic, toluene-p-sulphonic, hydrochloric, hydrobromic and sulphuric acids. Suitable alkylating agents are, for example, methyl and ethyl sulphates and alkyl halides. Suitable aralkylating agents are halides of formula Hal.(CH2)nAr in which n is not greater than 6 and Ar is an aromatic nucleus, particularly a phenyl, naphthyl or diphenyl nucleus, which may be additionally substituted by alkyl, alkoxy, halogen or nitro groups. The alkylating or aralkylating agent may have two reactive centres, e.g. it may be an aliphatic or araliphatic a .o -dichloride dibromide or diiodide. Suitable solvents are alkanols containing up to 5 carbon atoms, dioxan, and ethoxyethanol with or without the addition of water. The monopiperazinium salts used as starting materials may be prepared by reacting the corresponding acid with piperazine hexahydrate and may be formed in situ. Examples are given of the preparation of (a) N-substituted piperazines in which the N-substituent is m-methylbenzyl, methyl, n-amyl, o-methylbenzyl, p-methoxy benzyl, p - chlorobenzyl, a - naphthylmethyl, 6 - (1.2.3.4 - tetrahydronaphthyl) - methyl, b - phenethyl, g - phenylpropyl, 6 - phenylhexyl, g - o - toloxypropyl, g - 2.6 - xyloxypropyl and ethyl; and (b) 1.3 - bis - Npiperazino propane and 1.2-bis-N-piperazinoethane.
GB3189057A 1957-10-11 1957-10-11 Improvements in or relating to the manufacture of n-mono-substituted piperazines Expired GB840358A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3189057A GB840358A (en) 1957-10-11 1957-10-11 Improvements in or relating to the manufacture of n-mono-substituted piperazines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3189057A GB840358A (en) 1957-10-11 1957-10-11 Improvements in or relating to the manufacture of n-mono-substituted piperazines

Publications (1)

Publication Number Publication Date
GB840358A true GB840358A (en) 1960-07-06

Family

ID=10329919

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3189057A Expired GB840358A (en) 1957-10-11 1957-10-11 Improvements in or relating to the manufacture of n-mono-substituted piperazines

Country Status (1)

Country Link
GB (1) GB840358A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026196A2 (en) * 1995-02-23 1996-08-29 Schering Corporation Benzylpiperidines and piperazines as muscarinic antagonists
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
WO2006039974A1 (en) * 2004-10-11 2006-04-20 Merck Patent Gmbh Method for the production of monosubstituted piperazine derivatives
WO2005082893A3 (en) * 2004-02-25 2006-04-20 Lilly Co Eli Histamine h3 receptor antagonists, preparation and therapeutic uses
JP2013023489A (en) * 2011-07-25 2013-02-04 Tosoh Corp Method for producing n-alkyl piperazines
US8541578B2 (en) 2002-06-24 2013-09-24 Janssen Pharmaceutica, N.V. Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide
CZ304520B6 (en) * 2011-12-20 2014-06-11 Masarykova Univerzita Method of piperazine direct mono-N-substitution
CZ305854B6 (en) * 2011-12-20 2016-04-13 Masarykova Univerzita Process of direct piperazine mono-N-substitution

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026196A2 (en) * 1995-02-23 1996-08-29 Schering Corporation Benzylpiperidines and piperazines as muscarinic antagonists
WO1996026196A3 (en) * 1995-02-23 1996-10-03 Schering Corp Benzylpiperidines and piperazines as muscarinic antagonists
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
US6043255A (en) * 1995-02-23 2000-03-28 Schering Corporation Muscarinic antagonists
US8541578B2 (en) 2002-06-24 2013-09-24 Janssen Pharmaceutica, N.V. Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide
WO2005082893A3 (en) * 2004-02-25 2006-04-20 Lilly Co Eli Histamine h3 receptor antagonists, preparation and therapeutic uses
US7902191B2 (en) 2004-02-25 2011-03-08 Eli Lilly And Company Histamine H3 receptor antagonists, preparation and therapeutic uses
WO2006039974A1 (en) * 2004-10-11 2006-04-20 Merck Patent Gmbh Method for the production of monosubstituted piperazine derivatives
JP2013023489A (en) * 2011-07-25 2013-02-04 Tosoh Corp Method for producing n-alkyl piperazines
CZ304520B6 (en) * 2011-12-20 2014-06-11 Masarykova Univerzita Method of piperazine direct mono-N-substitution
CZ305854B6 (en) * 2011-12-20 2016-04-13 Masarykova Univerzita Process of direct piperazine mono-N-substitution

Similar Documents

Publication Publication Date Title
GB840358A (en) Improvements in or relating to the manufacture of n-mono-substituted piperazines
SE8202034L (en) NEW CHEMICAL PROCEDURE FOR THE PREPARATION OF PROPIONITRIL DERIVATIVES
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
GB942761A (en) Method of preparing amides
GB714230A (en) Pyridine compounds and process for the manufacture thereof
US2655503A (en) Quaternary salts of y-stilbazolines
GB821242A (en) Quaternary ammonium compounds
GB858719A (en) New quaternary ammonium compounds and a process for their manufacture
GB860336A (en) N-substituted 2-phenyl-7-aminoalkoxy chromones and a process for preparing them
GB824357A (en) Process for preparing hydrazinium salts
GB789273A (en) Trichloro-methyl-mercaptan derivatives and production
NL153194B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING AN ACID ADDITIONAL SALT OF A SUBSTITUTED PYRIDYL GROUP CONTAINING N-SUBSTITUATED DERIVATIVE OF THE N '- (3-P-FLUORBENZOYLPROEPORMINE, USED BEFORE INSERTING MEDIPROPROPYL, USED BEFORE INSERTING MEDIPROPROPYL) PREPARATION OF SUCH COMPOUNDS.
GB740130A (en) Derivatives of 4-cyclohexyl-cyclohexanone and process for the manufacture thereof
GB788121A (en) An improved process for the preparation of piperazine
GB695421A (en) Process for the production of organic iron and aluminium compounds
GB611593A (en) Improvements in the manufacture of primary amines
GB837266A (en) Aromatic amides of trialkoxybenzoic acids
ES360859A1 (en) Procedure for the preparation of new derivatives of tiazepine. (Machine-translation by Google Translate, not legally binding)
GB890533A (en) Improvements in or relating to heterocyclic quaternary ammonium salts
GB1096589A (en) Novel quinolizidine derivatives or salts thereof and process for preparing the same
GB751172A (en) 6-(-a-diethylamino-ethoxy)-2-dimethylamino-benzthiazole monohydrochloride and process for the manufacture thereof
GB800114A (en) Method of preparing derivatives from usnic acid
GB724863A (en) Improvements in or relating to therapeutic agents
ES389463A1 (en) Cephalosporanic acids
GB845021A (en) Improvements in or relating to sulphonium compounds